User profiles for Chandler S. Cortina
 | Chandler S Cortina, MD, MS, FSSO, FACSAssistant Professor, Medical College of Wisconsin Verified email at mcw.edu Cited by 267 |
Breast cancer risk and screening in transgender persons: a call for inclusive care
The Society of Surgical Oncology is committed to reducing health disparities adversely affecting
sexual and gender minorities. Transgender persons represent a socially disadvantaged …
sexual and gender minorities. Transgender persons represent a socially disadvantaged …
Postoperative complications from breast and axillary surgery
SZ Thalji, CS Cortina, MS Guo, AL Kong - Surgical Clinics, 2023 - surgical.theclinics.com
The prospective benefit of any operation must be weighed against the risk of its complications.
Although surgery of the breast and axilla is generally well tolerated by patients, the breast …
Although surgery of the breast and axilla is generally well tolerated by patients, the breast …
Inclusion and reporting of transgender and nonbinary persons in clinical trials and tumor registries—the time is now
CS Cortina - JAMA oncology, 2022 - jamanetwork.com
An increasing number of adults in the US identify as transgender or nonbinary. 1 Transgender
refers to a person whose gender identity does not align with the sex they were assigned at …
refers to a person whose gender identity does not align with the sex they were assigned at …
Bile duct injuries: a contemporary survey of surgeon attitudes and experiences
R Fletcher, CS Cortina, H Kornfield, A Varelas, R Li… - Surgical …, 2020 - Springer
Introduction The incidence of bile duct injury (BDI) during laparoscopic cholecystectomy has
not changed significantly in the past 2 decades despite increased operative experience and …
not changed significantly in the past 2 decades despite increased operative experience and …
National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial
…, M Teshome, AL Kong, P Singh, CS Cortina - Breast Cancer Research …, 2024 - Springer
Purpose Neoadjuvant chemotherapy (NAC) for triple-negative breast cancer (TNBC) allows
for assessment of tumor pathological response and has survival implications. In 2017, the …
for assessment of tumor pathological response and has survival implications. In 2017, the …
Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy
…, AL Kong, C Patten, T Yen, CS Cortina… - Breast Cancer Research …, 2023 - Springer
Background Endocrine resistant metastatic disease develops in ~ 20–25% of hormone-receptor-positive
(HR+) breast cancer (BC) patients despite endocrine therapy (ET) use. …
(HR+) breast cancer (BC) patients despite endocrine therapy (ET) use. …
Invasive breast cancer treatment patterns in women age 80 and over: a report from the National Cancer Database
J Frebault, C Bergom, CS Cortina, ME Shukla… - Clinical breast …, 2022 - Elsevier
Background There are no established treatment guidelines for women with breast cancer
aged ≥80 despite increasing representation in the US population. Here we identify national …
aged ≥80 despite increasing representation in the US population. Here we identify national …
National trends in “going flat” after mastectomy
MK Johnson, CS Cortina, TL Hsu, S Huang… - Annals of Surgical …, 2023 - Springer
Introduction The “Going Flat” movement became widely publicized in 2016 and provides
information and support to women who choose to forego post-mastectomy breast reconstruction …
information and support to women who choose to forego post-mastectomy breast reconstruction …
Perceptions of transgender and nonbinary persons toward breast and cervical cancer development, screening, and potential impact on gender-affirming hormone …
…, AEB Lakatos, R Narayan, CS Cortina - JCO Oncology …, 2023 - ascopubs.org
PURPOSE: Approximately 1.6% of adult Americans identify as transgender (TG) or nonbinary
(NB) and many take gender-affirming hormone therapy (GAHT). Little data exist to inform …
(NB) and many take gender-affirming hormone therapy (GAHT). Little data exist to inform …
A national survey of breast surgeons and radiation oncologists on contemporary axillary management in mastectomy patients
CS Cortina, C Bergom, MA Craft, B Fields… - Annals of Surgical …, 2021 - Springer
Background Management of axillary lymph nodes in breast cancer has undergone significant
change over the past decade through landmark clinical trials. This study aimed to assess …
change over the past decade through landmark clinical trials. This study aimed to assess …